Lindbrook Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.77K | Hold |
85
| – | – | ﹤0.01% | 2317 |
|
|
2024
Q4 | $2K | Sell |
85
-105
| -55% | -$2.47K | ﹤0.01% | 2305 |
|
|
2024
Q3 | $4.86K | Sell |
190
-400
| -68% | -$10.2K | ﹤0.01% | 2024 |
|
|
2024
Q2 | $13.9K | Hold |
590
| – | – | ﹤0.01% | 1448 |
|
|
2024
Q1 | $17K | Hold |
590
| – | – | ﹤0.01% | 1297 |
|
|
2023
Q4 | $19.4K | Hold |
590
| – | – | ﹤0.01% | 1198 |
|
|
2023
Q3 | $16.4K | Hold |
590
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q2 | $20.1K | Sell |
590
-7
| -1% | -$239 | ﹤0.01% | 1087 |
|
|
2023
Q1 | $18K | Buy |
597
+7
| +1% | +$210 | ﹤0.01% | 1123 |
|
|
2022
Q4 | $16.7K | Buy |
590
+100
| +20% | +$2.82K | ﹤0.01% | 1161 |
|
|
2022
Q3 | $16K | Hold |
490
| – | – | ﹤0.01% | 1092 |
|
|
2022
Q2 | $15K | Hold |
490
| – | – | ﹤0.01% | 1081 |
|
|
2022
Q1 | $23K | Buy |
490
+80
| +20% | +$3.76K | ﹤0.01% | 944 |
|
|
2021
Q4 | $25K | Buy |
410
+305
| +290% | +$18.6K | ﹤0.01% | 938 |
|
|
2021
Q3 | $8K | Buy |
105
+100
| +2,000% | +$7.62K | ﹤0.01% | 1070 |
|
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 1908 |
|
|
2021
Q1 | $0 | Buy |
5
+4
| +400% | – | ﹤0.01% | 1864 |
|
|
2020
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1769 |
|